# GSTA4

## Overview
The GSTA4 gene encodes the enzyme glutathione S-transferase alpha 4 (GSTA4-4), a member of the glutathione S-transferase (GST) family, which is involved in the detoxification of endogenous and exogenous compounds. GSTA4-4 is a cytosolic enzyme that plays a pivotal role in cellular defense mechanisms by catalyzing the conjugation of glutathione to toxic lipid peroxidation products, such as 4-hydroxynonenal (4-HNE), thereby mitigating oxidative stress and cellular damage (Mazari2023The; Singhal2015Antioxidant). The enzyme is characterized by a canonical GST fold and functions as a homodimer, with each subunit containing specific binding sites for glutathione and electrophilic substrates (Bruns1999Human; Balogh2010Substrate). GSTA4-4 is particularly significant in the liver, where it contributes to detoxification pathways, and its activity is crucial in various physiological processes, including cell signaling and apoptosis regulation (Mazari2023The; Gallagher2007Transfection). Alterations in GSTA4 expression or function have been linked to several diseases, including neurodegenerative disorders and cancer, underscoring its importance in maintaining cellular homeostasis and its potential as a therapeutic target (Jewett2018Glutathione; Townsend2003Cancer).

## Structure
The human glutathione transferase A4-4 (GSTA4) enzyme is characterized by a canonical GST fold, comprising two structural domains. The N-terminal domain features a mixed beta-sheet flanked by alpha-helices, responsible for most substrate interactions, while the C-terminal domain is primarily alpha-helical (Bruns1999Human). The enzyme forms a homodimer, with each subunit containing a glutathione-binding site (G-site) and an electrophile binding site (H-site) (Balogh2010Substrate). The G-site is highly conserved, involving residues such as Tyr9 and Arg15, which are crucial for glutathione binding (Bruns1999Human).

The H-site is formed by three substrate recognition regions, including the a1-b1 loop, the end of the a4 helix, and the a9 helix, which are distant in the primary structure but close in the folded protein (Bruns1999Human). Tyr212 is a key residue in the H-site, playing a significant role in substrate specificity and catalytic efficiency, particularly with 4-hydroxynonenal (HNE) (Bruns1999Human). The enzyme's structure is stabilized by interactions such as an edge-on-face aromatic-aromatic interaction between Phe111 and Tyr217, which aids in the pre-organization of the C-terminus for HNE binding (Balogh2010Substrate).

## Function
The human gene GSTA4 encodes the enzyme glutathione S-transferase alpha 4 (GSTA4-4), which plays a crucial role in detoxifying harmful compounds in cells. GSTA4-4 is particularly effective in catalyzing the conjugation of glutathione (GSH) to 4-hydroxynonenal (4-HNE), a toxic product of lipid peroxidation. This process is essential for maintaining cellular homeostasis by reducing the cytotoxic and genotoxic effects of 4-HNE, which can otherwise lead to oxidative stress and cellular damage (Mazari2023The; Singhal2015Antioxidant).

GSTA4-4 is primarily active in the cytoplasm and is involved in various cellular processes, including cell signaling and the regulation of apoptosis. By modulating the intracellular concentration of 4-HNE, GSTA4-4 helps prevent the activation of pro-apoptotic signaling pathways, such as those mediated by Fas and p53, thereby protecting cells from oxidative stress-induced cytotoxicity (Singhal2015Antioxidant).

The enzyme's activity is particularly significant in the liver, where it contributes to detoxification pathways, rendering electrophilic compounds less toxic and facilitating their export from the cell. This function is part of the broader role of glutathione S-transferases in detoxifying carcinogens, therapeutic agents, and oxidative stress products (Mazari2023The; Gallagher2007Transfection).

## Clinical Significance
Alterations in the expression or function of the GSTA4 gene have been implicated in several diseases and conditions. In neurodegenerative diseases such as Parkinson's disease (PD), GSTA4 is involved in detoxifying lipid peroxidation by-products like 4-hydroxynonenal (HNE), which are elevated in PD brains. Higher expression levels of GSTA4 in certain rat models are associated with reduced dopaminergic neuron loss, suggesting a protective role against neurodegeneration (Jewett2018Glutathione). 

In cardiovascular health, GSTA4 plays a role in protecting the heart from oxidative and electrophilic stress. Gsta4-null mice, which lack this gene, show a compensatory increase in Nrf2 pathway activity, which helps maintain normal levels of oxidative stress markers. These mice also exhibit reduced sensitivity to doxorubicin-induced cardiotoxicity, indicating a potential protective mechanism against oxidative damage (Beneš2013Protection).

GSTA4 is also involved in cancer, where its expression is decreased in hepatocellular carcinoma. The enzyme's role in detoxifying lipid peroxidation products suggests it may influence drug metabolism and resistance, highlighting its importance in pharmacogenomics and cancer treatment (Townsend2003Cancer).


## References


[1. (Balogh2010Substrate) Larissa M. Balogh, Isolde Le Trong, Kimberly A. Kripps, Laura M. Shireman, Ronald E. Stenkamp, Wei Zhang, Bengt Mannervik, and William M. Atkins. Substrate specificity combined with stereopromiscuity in glutathione transferase a4-4-dependent metabolism of 4-hydroxynonenal. Biochemistry, 49(7):1541–1548, January 2010. URL: http://dx.doi.org/10.1021/bi902038u, doi:10.1021/bi902038u. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi902038u)

[2. (Mazari2023The) Aslam M. A. Mazari, Leilei Zhang, Zhi-Wei Ye, Jie Zhang, Kenneth D. Tew, and Danyelle M. Townsend. The multifaceted role of glutathione s-transferases in health and disease. Biomolecules, 13(4):688, April 2023. URL: http://dx.doi.org/10.3390/biom13040688, doi:10.3390/biom13040688. This article has 55 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom13040688)

[3. (Gallagher2007Transfection) Evan P. Gallagher, Christiaan M. Huisden, and James L. Gardner. Transfection of hepg2 cells with hgsta4 provides protection against 4-hydroxynonenal-mediated oxidative injury. Toxicology in Vitro, 21(8):1365–1372, December 2007. URL: http://dx.doi.org/10.1016/j.tiv.2007.04.004, doi:10.1016/j.tiv.2007.04.004. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.tiv.2007.04.004)

[4. (Townsend2003Cancer) Danyelle M Townsend and Kenneth D Tew. Cancer drugs, genetic variation and the glutathione-s-transferase gene family. American Journal of PharmacoGenomics, 3(3):157–172, 2003. URL: http://dx.doi.org/10.2165/00129785-200303030-00002, doi:10.2165/00129785-200303030-00002. This article has 112 citations.](https://doi.org/10.2165/00129785-200303030-00002)

[5. (Singhal2015Antioxidant) Sharad S. Singhal, Sharda P. Singh, Preeti Singhal, David Horne, Jyotsana Singhal, and Sanjay Awasthi. Antioxidant role of glutathione s-transferases: 4-hydroxynonenal, a key molecule in stress-mediated signaling. Toxicology and Applied Pharmacology, 289(3):361–370, December 2015. URL: http://dx.doi.org/10.1016/j.taap.2015.10.006, doi:10.1016/j.taap.2015.10.006. This article has 159 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.taap.2015.10.006)

[6. (Beneš2013Protection) Helen Beneš, Mai K. Vuong, Marjan Boerma, Kevin E. McElhanon, Eric R. Siegel, and Sharda P. Singh. Protection from oxidative and electrophilic stress in the gsta4-null mouse heart. Cardiovascular Toxicology, 13(4):347–356, May 2013. URL: http://dx.doi.org/10.1007/s12012-013-9215-1, doi:10.1007/s12012-013-9215-1. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12012-013-9215-1)

[7. (Jewett2018Glutathione) Michael Jewett, Elna Dickson, Kajsa Brolin, Matilde Negrini, Itzia Jimenez-Ferrer, and Maria Swanberg. Glutathione s-transferase alpha 4 prevents dopamine neurodegeneration in a rat alpha-synuclein model of parkinson’s disease. Frontiers in Neurology, April 2018. URL: http://dx.doi.org/10.3389/fneur.2018.00222, doi:10.3389/fneur.2018.00222. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fneur.2018.00222)

[8. (Bruns1999Human) Christopher M Bruns, Ina Hubatsch, Marianne Ridderström, Bengt Mannervik, and John A Tainer. Human glutathione transferase a4-4 crystal structures and mutagenesis reveal the basis of high catalytic efficiency with toxic lipid peroxidation products. Journal of Molecular Biology, 288(3):427–439, May 1999. URL: http://dx.doi.org/10.1006/jmbi.1999.2697, doi:10.1006/jmbi.1999.2697. This article has 153 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1006/jmbi.1999.2697)